ArticleTherapeutic advances in medical oncology2022

Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC.

Simon A Keek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.